The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Miller Steve since 2015.
This trader's CIK number is 1402535.
At the time of last reporting, Miller Steve was the Chief Op. & Scientific Officer of Catalyst Pharmaceuticals, Inc.. (stock ticker symbol CPRX).
Also see all insider trading activities at Catalyst Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CPRX | 0 | $0 | 115,000 | $2,332,200 | 238,667 | $504,000 |
| 2024 | CPRX | 0 | $0 | 200,000 | $4,149,300 | 324,539 | $1,142,850 |
| 2023 | CPRX | 0 | $0 | 40,000 | $569,600 | 264,000 | $248,499 |
| 2022 | CPRX | 0 | $0 | 307,933 | $4,971,205 | 20,000 | $0 |
| 2021 | CPRX | 0 | $0 | 120,963 | $694,063 | 205,000 | $577,200 |
| 2020 | CPRX | 0 | $0 | 0 | $0 | 20,000 | $0 |
| 2017 | CPRX | 0 | $0 | 0 | $0 | 200,000 | $94,000 |
| 2016 | CPRX | 7,933 | $14,279 | 0 | $0 | 0 | $0 |
| 2015 | CPRX | 0 | $0 | 0 | $0 | 60,000 | $65,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-26 | CPRX | Option Ex | 115,000 | 2.24 | 257,600 |
| 2025-08-27 | CPRX | Option Ex | 110,000 | 2.24 | 246,400 |
| 2025-08-26 | CPRX | Sale | 115,000 | 20.28 | 2,332,200 |
| 2025-02-14 | CPRX | Option Ex | 13,667 | .00 | 0 |
| 2024-12-27 | CPRX | Option Ex | 14,000 | .00 | 0 |
| 2024-12-13 | CPRX | Option Ex | 235,000 | 4.01 | 942,350 |
| 2024-12-10 | CPRX | Sale | 50,000 | 21.93 | 1,096,350 |
| 2024-12-10 | CPRX | Option Ex | 50,000 | 4.01 | 200,500 |
| 2024-12-09 | CPRX | Option Ex | 11,872 | .00 | 0 |
| 2024-08-20 | CPRX | Sale | 150,000 | 20.35 | 3,052,950 |
| 2024-02-15 | CPRX | Option Ex | 13,667 | .00 | 0 |
| 2023-12-27 | CPRX | Option Ex | 14,000 | .00 | 0 |
| 2023-12-11 | CPRX | Option Ex | 150,000 | 1.13 | 169,499 |
| 2023-12-05 | CPRX | Sale | 40,000 | 14.24 | 569,600 |
| 2023-05-11 | CPRX | Option Ex | 100,000 | .79 | 79,000 |
| 2022-12-06 | CPRX | Option Ex | 20,000 | .00 | 0 |
| 2022-11-21 | CPRX | Sale | 80,000 | 15.28 | 1,222,080 |
| 2022-11-23 | CPRX | Sale | 20,000 | 17.34 | 346,740 |
| 2022-11-21 | CPRX | Sale | 80,000 | 15.28 | 1,222,080 |
| 2022-11-23 | CPRX | Sale | 20,000 | 17.34 | 346,740 |
| 2022-09-13 | CPRX | Sale | 107,933 | 16.99 | 1,833,565 |
| 2021-12-03 | CPRX | Option Ex | 20,000 | .00 | 0 |
| 2021-08-25 | CPRX | Sale | 80,000 | 5.56 | 444,640 |
| 2021-08-25 | CPRX | Option Ex | 120,000 | 3.12 | 374,400 |
| 2021-08-13 | CPRX | Option Ex | 65,000 | 3.12 | 202,800 |
| 2021-08-13 | CPRX | Sale | 40,963 | 6.09 | 249,423 |
| 2020-12-22 | CPRX | Option Ex | 20,000 | .00 | 0 |
| 2017-11-06 | CPRX | Option Ex | 200,000 | .47 | 94,000 |
| 2016-01-11 | CPRX | Buy | 7,933 | 1.80 | 14,279 |
| 2015-08-25 | CPRX | Option Ex | 60,000 | 1.09 | 65,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Miller Steve (Chief Op. & Scientific Officer of Catalyst Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.